These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22929525)

  • 1. Recurrent toxic epidermal necrolysis secondary to iopromide contrast.
    Brown M; Yowler C; Brandt C
    J Burn Care Res; 2013; 34(1):e53-6. PubMed ID: 22929525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autopsy case of malignant lymphoma with Lyell's syndrome.
    Sadi AM; Toda T; Kiyuna M; Tamamoto T; Ohshiro K; Shinzato R
    J Dermatol; 1995 Aug; 22(8):594-9. PubMed ID: 7560459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center.
    Ellis MW; Oster CN; Turiansky GW; Blanchard JR
    Mil Med; 2002 Aug; 167(8):701-4. PubMed ID: 12188246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.
    Huang LY; Liao WC; Chiou CC; Lou JP; Hu P; Ko FC
    J Formos Med Assoc; 2007 Dec; 106(12):1032-7. PubMed ID: 18194909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
    Fallon MJ; Heck JN
    J Oncol Pharm Pract; 2015 Oct; 21(5):388-92. PubMed ID: 25005569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis - an investigation to dye for?
    Ly T; Stewart N; Lee S
    Med J Aust; 2015 Jan; 202(1):51-2. PubMed ID: 25588447
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxic epidermal necrolysis - an investigation to dye for?
    Ridley LJ; Limaye S
    Med J Aust; 2015 Jul; 203(2):76-8. PubMed ID: 26175241
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe Cutaneous Adverse Reactions Following Intravenous Contrast: A Report of 2 Cases.
    Yang SS; Aw DC; Chandran NS
    Ann Acad Med Singap; 2015 Dec; 44(12):561-4. PubMed ID: 27090074
    [No Abstract]   [Full Text] [Related]  

  • 10. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lin A; Patel N; Yoo D; DeMartelaere S; Bouchard C
    J Burn Care Res; 2011; 32(5):547-60. PubMed ID: 21799437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative beta-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability.
    Paquet P; Jacob E; Damas P; Piérard GE
    Crit Care Med; 2002 Nov; 30(11):2580-3. PubMed ID: 12441773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis incriminating iopamidol in a child after cardiac catheterization.
    Lee ML; Chiu IS
    Int J Cardiol; 2002 Jan; 82(1):95-7. PubMed ID: 11786169
    [No Abstract]   [Full Text] [Related]  

  • 15. Probable parenteral and oral contrast-induced Steven Johnson syndrome/toxic epidermal necrolysis.
    Pop M; Hemenway A; Shakeel F
    Am J Emerg Med; 2021 Jul; 45():684.e5-684.e6. PubMed ID: 33402308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 cases.
    Duong TA; Haddad C; Valeyrie-Allanore L; Sbidian E; Chosidow O; Wolkenstein P
    JAMA Dermatol; 2013 Jan; 149(1):113-5. PubMed ID: 23324778
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous immunoglobulin prophylaxis for recurrent Stevens-Johnson syndrome.
    Hebert AA; Bogle MA
    J Am Acad Dermatol; 2004 Feb; 50(2):286-8. PubMed ID: 14726889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Marfatia YS
    Arch Dermatol; 1994 Aug; 130(8):1073-4. PubMed ID: 8093181
    [No Abstract]   [Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus.
    Burge SM; Dawber RP
    J Am Acad Dermatol; 1985 Oct; 13(4):665-6. PubMed ID: 4078055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.